CCIT Change Control and Revalidation Trigger Assessment

Document type	Risk Assessment
Topic area	Drug Product
Level	Advanced
Updated	September 2026

This is a ready-to-use risk assessment for evaluating, at every change that could touch a container closure seal, whether the existing CCIT method validation and its acceptance criteria still apply. Attach it to the relevant change control record. Replace every <<FILL: ...>> placeholder with your own specifics and route it through your normal document control, review, and approval. A worked filled specimen follows. Verify each cited reference against the current source before you rely on it.

Document control header

Field	Entry
Document title	CCIT Revalidation Trigger Assessment for `<<FILL: change description>>`
Document number	`<<FILL: e.g. RA-CCIT-014>>`
Version	`<<FILL>>`
Effective date	`<<FILL>>`
Linked change control number	`<<FILL>>`
Linked CCIT study protocol / method validation	`<<FILL: ref>>`
Document owner	`<<FILL: e.g. Analytical / Packaging SME>>`

1. Purpose

This assessment determines whether a proposed change invalidates any part of the existing CCIT validation package, the method’s demonstrated sensitivity, the positive control basis, the seal quality acceptance range, or the maximum allowable leakage limit (MALL) itself, and defines the action required before the change is implemented.

2. Scope

Dimension	Decision
Change under assessment	`<<FILL>>`
Existing CCIT validation package referenced	`<<FILL: document number>>`
Container closure system affected	`<<FILL: vial, prefilled syringe, cartridge, cryobag>>`
Out of scope	`<<FILL: e.g. sterility test method itself, covered separately>>`

3. Responsibilities

Role	Responsibility
Analytical / packaging SME	Facilitates the assessment, owns the conclusion and any follow-up validation scope
Change control owner	Ensures this assessment is triggered and closed before the change is implemented
Manufacturing / fill-finish operations	Confirms whether the change is already reflected in the in-line seal quality monitoring range
Quality Assurance	Approves the conclusion and any decision that no further CCIT work is required

4. Change classification

Classify the change against the categories below. More than one applicable row widens the scope of follow-up work required.

Change type	Applicable?	Leak-test sensitivity affected?	Seal quality acceptance range affected?
Stopper, plunger, or closure material, geometry, or supplier changes	`<<FILL: Yes/No>>`	`<<FILL>>`	`<<FILL>>`
Crimp height, torque setting, or sealing machine parameter changes	`<<FILL: Yes/No>>`	`<<FILL>>`	`<<FILL>>`
Lyophilization cycle changes (affects headspace vacuum or gas state)	`<<FILL: Yes/No>>`	`<<FILL>>`	`<<FILL>>`
Primary packaging component changes prompted by an extractables and leachables finding	`<<FILL: Yes/No>>`	`<<FILL>>`	`<<FILL>>`
New or revised shipping lane, shipper, or thermal profile	`<<FILL: Yes/No>>`	`<<FILL>>`	`<<FILL>>`
Device assembly change (autoinjector, pen housing) that removes or changes post-assembly test access	`<<FILL: Yes/No>>`	`<<FILL>>`	`<<FILL>>`

5. Impact evaluation

Question	Answer
Does the change move the seal geometry or material outside what the original method validation’s positive controls represented?	`<<FILL>>`
Does the change alter the critical attribute the MALL was derived against (sterility, headspace gas or vacuum state, moisture)?	`<<FILL>>`
Does the change affect a seal location the original validation independently interrogated, or introduce a new seal location entirely?	`<<FILL>>`
Is the in-line seal quality (RSF or torque) acceptance range still linked to current leak-test evidence after this change?	`<<FILL>>`
Does the change remove non-destructive CCIT access once implemented (e.g. device assembly around a syringe)?	`<<FILL>>`

6. Conclusion and required action

Field	Entry
Existing CCIT validation package still applies without further work	`<<FILL: Yes/No>>`
If No, required action	`<<FILL: new positive control set / method re-validation / MALL re-derivation / seal quality acceptance range update>>`
Owner and target date for the required action	`<<FILL>>`
Can the change proceed before the action is complete?	`<<FILL: Yes/No, with justification>>`

7. References

USP General Chapter <1207>, Package Integrity Evaluation, General Considerations. USP General Chapter <1207.1>, Package Integrity Testing in the Container-Closure System. USP General Chapter <1207.3>, Package Seal Quality Test Technologies. See the paired article, Building a container closure integrity program under USP <1207>, for the underlying method-selection and revalidation-trigger logic this assessment works through.

Confirm the current version of each reference before issue.

8. Revision history

Version	Date	Author	Summary of change
`<<FILL: 1.0>>`	`<<FILL>>`	`<<FILL>>`	Initial issue.

9. Approvals

Role	Name	Signature	Date
Author (Analytical / Packaging)	`<<FILL>>`
Reviewer (Manufacturing / Fill-Finish)	`<<FILL>>`
Approver (QA)	`<<FILL>>`

Filled specimen

Extract for an example change control proposing a new elastomeric stopper supplier for a lyophilized biologic vial, prompted by a supply continuity concern with the incumbent vendor. Company and product are illustrative.

Change type	Applicable?	Leak-test sensitivity affected?	Seal quality acceptance range affected?
Stopper, plunger, or closure material, geometry, or supplier changes	Yes, new supplier’s stopper formulation and durometer differ from the qualified stopper	Yes	Yes
Crimp height, torque setting, or sealing machine parameter changes	No, crimp settings unchanged	Not applicable	Not applicable
Lyophilization cycle changes	No	Not applicable	Not applicable
Primary packaging component changes prompted by an E&L finding	No	Not applicable	Not applicable

Impact evaluation: the original positive controls and RSF acceptance range were established against the incumbent stopper’s compression set behavior; a different elastomer formulation relaxes under crimp pressure at a different rate, so the existing RSF acceptance range cannot be assumed to still predict integrity for the new stopper. The MALL itself, sterility-driven, does not change, since the critical attribute and its derivation are independent of which stopper supplier is used.

Conclusion: existing CCIT validation package does not cover the new stopper without further work. Required action: run a new positive control set (laser-drilled holes bracketing the existing MALL) against the new stopper lot to confirm leak-test sensitivity is unchanged, and re-establish the RSF acceptance range against the new stopper’s compression behavior, tied back to that new leak-test evidence. Owner: Analytical / Packaging SME, target date set to precede first commercial use of the new stopper lot. The change cannot proceed to commercial batches until both the positive control confirmation and the revised RSF range are approved; QA holds the change control open pending that data.

Common inspection findings this risk assessment prevents

A stopper or supplier change implemented through change control with no linked CCIT impact review.
An in-line seal quality acceptance range left unchanged after a closure change, so it no longer predicts what it claims to predict.
A device-assembly change that quietly removes CCIT test access, discovered only after the fact.
A conclusion of “no impact” reached with no documented comparison against what the original validation’s positive controls actually represented.

How to adapt this risk assessment

Link this assessment to the actual change control record in the header, not as a standalone document.
Classify the change honestly against every row in section 4; more than one applicable row is common.
Where the seal quality acceptance range is affected, do not close this assessment until that range is re-tied to new leak-test evidence, not just carried forward unchanged.
Confirm every reference in section 7 against the current published version before issue.